<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c90> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c90> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.sgn_40>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c90> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.non-hodgkin_lymphoma>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c90> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c90> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
_:MYGoYXks1335 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/en>.
_:MYGoYXks1335 <http://rdf.freebase.com/ns/type.value.value> "sgn_40".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c88> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c88> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.sgn_40>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c88> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.multiple_myeloma>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c88> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c88> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.product.developed_by> <http://rdf.freebase.com/ns/en.genentech>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.product.developed_by> <http://rdf.freebase.com/ns/en.seattle_genetics_inc>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/xhtml/vocab#license> <http://creativecommons.org/licenses/by/3.0/>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://creativecommons.org/ns#attributionName> "Source: Freebase - The World's database".
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/medicine.drug>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/medicine.medical_treatment>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.product>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.topic>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c90>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e087>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008ce0c88>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/type.object.name> "SGN-40"@en.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.biomolecule_or_target> <http://rdf.freebase.com/ns/en.cd40>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.product.technology_involved> <http://rdf.freebase.com/ns/en.monoclonal_antibodies>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.product.technology_involved> <http://rdf.freebase.com/ns/en.humanized_monoclonal_antibody>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/base.bioventurist.product.stage_of_development> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008cddd3d>.
<http://rdf.freebase.com/ns/en.sgn_40> <http://rdf.freebase.com/ns/type.object.key> _:MYGoYXks1335.
<http://rdf.freebase.com/ns/en.sgn_40> <http://creativecommons.org/ns#attributionURL> <http://www.freebase.com/view/en/sgn_40>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e087> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e087> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.sgn_40>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e087> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.b-cell_lymphoma>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e087> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e087> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.